Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway
出版年份 2022 全文链接
标题
Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway
作者
关键词
-
出版物
Nutrients
Volume 14, Issue 9, Pages 1983
出版商
MDPI AG
发表日期
2022-05-10
DOI
10.3390/nu14091983
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Gout
- (2021) Nicola Dalbeth et al. LANCET
- Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
- (2021) Eun Ha Kang et al. EUROPEAN HEART JOURNAL
- Dioscin ameliorates methotrexate-induced liver and kidney damages via adjusting miRNA-145-5p-mediated oxidative stress
- (2021) Y. Li et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dioscin: A review on pharmacological properties and therapeutic values
- (2021) Shinjini Bandopadhyay et al. BIOFACTORS
- The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study
- (2020) Jing Liang et al. Lipids in Health and Disease
- Serum Uric Acid Is Independently Associated with Aortic Arch Calcification in a Cross-Sectional Study of Middle-aged and Elderly Women
- (2020) Wei Yan et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial
- (2020) Atsushi Tanaka et al. PLOS MEDICINE
- Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver
- (2020) Ning Liu et al. FASEB JOURNAL
- Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
- (2020) Oren Rom et al. Science Translational Medicine
- The role of statins in the management of nonalcoholic fatty liver disease
- (2019) Michael Doumas et al. CURRENT PHARMACEUTICAL DESIGN
- Longitudinal association between serum uric acid levels and multiterritorial atherosclerosis
- (2019) Meiyue Song et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis
- (2019) Qining Yang et al. PHARMACOLOGICAL RESEARCH
- PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
- (2019) Rajashree Rana et al. Molecular Metabolism
- Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol
- (2019) Marios K Georgakis et al. BRAIN
- Mechanisms and regulation of cholesterol homeostasis
- (2019) Jie Luo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Effect of Eurycoma longifolia Stem Extract on Uric Acid Excretion in Hyperuricemia Mice
- (2019) Ruixia Bao et al. Frontiers in Pharmacology
- A Reappraisal of the Lipid Hypothesis ✰,✰✰
- (2018) Robert DuBroff AMERICAN JOURNAL OF MEDICINE
- Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan
- (2018) Masanari Kuwabara et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia
- (2018) Yi Zhang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Hypothyroidism affects lipid and glycogen content and peroxisome proliferator-activated receptor ? expression in the ovary of the rabbit
- (2018) Julia Rodr�guez-Castel�n et al. REPRODUCTION FERTILITY AND DEVELOPMENT
- Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk
- (2018) Claudio Borghi et al. Cardiology Journal
- Intracellular Cholesterol Transport by Sterol Transfer Proteins at Membrane Contact Sites
- (2018) Jie Luo et al. TRENDS IN BIOCHEMICAL SCIENCES
- The mystery of membrane organization: composition, regulation and roles of lipid rafts
- (2017) Erdinc Sezgin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- 2016 updated EULAR evidence-based recommendations for the management of gout
- (2016) P Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Dyslipidemia in patients with chronic kidney disease
- (2016) Matthew R. Hager et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- UPLC-QTOF-MS identification of metabolites in rat biosamples after oral administration of Dioscorea saponins: A comparative study
- (2015) Yi-Na Tang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis
- (2015) Rui Liu et al. Biomed Research International
- Relationship between Hyperuricemia and Lipid Profiles in US Adults
- (2015) Tao-Chun Peng et al. Biomed Research International
- Danhong Injection Inhibits the Development of Atherosclerosis in Both Apoe−/− and Ldlr−/− Mice
- (2014) Yuanli Chen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
- (2008) M K Reinders et al. ANNALS OF THE RHEUMATIC DISEASES
- Uric Acid and Cardiovascular Risk
- (2008) Daniel I. Feig et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation